BDBM379557 US9926281, Compound 36

SMILES Cc1ccc(Cl)cc1N1CCN(CC1)C(=O)CCC1(NC(=O)NC1=O)C1CC1

InChI Key InChIKey=IYBHJPNFVKYDOX-UHFFFAOYSA-N

Data  26 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 26 hits for monomerid = 379557   

LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 651nMAssay Description:Inhibition of human recombinant TACE (AA34 to 660) assessed as cleavage of fluorescent substrate using 5FAM-LAQAVRSSSRK-5TAMRA as substrate by bioche...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMacrophage metalloelastase(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 6.78E+3nMAssay Description:Inhibition of MMP-12 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCollagenase 3(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of MMP-13 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of MMP-9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil collagenase(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of MMP-8 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMatrilysin(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of MMP-7 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetStromelysin-1(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of MMP-3 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetInterstitial collagenase(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of MMP-1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetDipeptidyl peptidase 4(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of DPP-IV (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin D(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Cathepsin D (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCaspase-3(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Caspase 3 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of ADAM-10 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of ADAM-9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetADAMTS5(Rat)
Galapagos

US Patent
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 29nMAssay Description:ADAMTS-4:The basis for the assay is the cleavage of the substrate TBIS-1 (5-FAM-TEGEARGSVILLK (5TAMRA)K-NH2) (SEQ ID No 2) by human ADAMTS4For the do...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMatrix metalloproteinase-14(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human recombinant MMP14 (AA112 to 298) assessed as cleavage of fluorescent substrate using 390 MMP FRET as substrate incubated for 30 m...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Target72 kDa type IV collagenase(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human recombinant MMP2 (AA34 to 660) assessed as cleavage of fluorescent substrate using 390 MMP FRET as substrate incubated for 30 min...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 428nMAssay Description:Inhibition of human recombinant ADAMTS-4 (AA1 to 520) assessed as cleavage of fluorescent substrate using as TBIS-1 substrate incubated for 180 mins ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human recombinant ADAMTS-1 (AA253 to 734) assessed as cleavage of fluorescent substrate using 5(6)-fluorescein-NH-AELQGRPISIAK-5(6)-TAM...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 34nMAssay Description:Inhibition of human recombinant ADAMTS-5 assessed as cleavage of fluorescent substrate using FAM-TBIS-1 by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMatrix metalloproteinase-14(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:MMP-14:The basis for the assay is the cleavage of the substrate 390 MMP FRET Substrate I (Anaspec Cat # AS-27076) by human MMP14 (Biomol, Cat #SE-259...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCollagenase 3(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:MMP-13:The basis for the assay is the cleavage of the substrate 390 MMP FRET Substrate I (Anaspec Cat # AS-27076) by human MMP13 (Chemicon, Cat #CC06...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target72 kDa type IV collagenase(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:MMP2: Protocol 2: The basis for the assay is the cleavage of the substrate 390 MMP FRET substrate I (Anaspec, Catalog n#: AS-27076) by human MMP2 (R&...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target72 kDa type IV collagenase(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 2.00E+4nMAssay Description:MMP2: Protocol 1: The basis for the assay is the cleavage of the substrate 520 MMP fret substrate XV (Anaspec, Catalog #: AS-60582-01) by human MMP2 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterstitial collagenase(Human)
Galapagos

Curated by ChEMBL
LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of the proteases human MMP1 was determined at REACTION BIOLOGY (Reaction Biology Corp. 1 Great Valley Parkway, Suite 2 Malvern, Pa. 19355,...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 670nMAssay Description:TACE:The basis for the assay is the cleavage of the substrate 5FAM-LAQAVRSSSRK-5TAMRA (SEQ ID No 3) (Anaspec, custom 34891) by human TACE (R&D SYSTEM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM379557(US9926281, Compound 36)
Affinity DataIC50: 34nMAssay Description:ADAMTS-5:Protocol 1: The basis for the assay is the cleavage of the substrate TBIS-1 (5 FAM-TEGEARGSVILLK (5TAMRA)K-NH2) (SEQ ID No 2) by human ADAMT...More data for this Ligand-Target Pair
In DepthDetails
US Patent